Bureau Veritas offers an 8.1/10 defensive compounding profile as portfolio rotation, data-center growth, and regulatory demand support a probability-weighted five-year value of €44.15.
Overview
Bureau Veritas is a global TIC leader operating since 1828, generating revenue from laboratory testing, recurring regulatory inspections, asset-integrity programs, and project-based certifications. Its diversified exposure spans Buildings & Infrastructure, Industry, commodities, Marine, Consumer Products, and Certification, while more than 1,000 accredited laboratories across 140 countries create meaningful scale and switching-cost advantages. **The financial trajectory is improving:** H1 2026 revenue rose 2.1% reported and 5.0% organically to €3,258.4 million, adjusted operating margin increased to 15.5%, adjusted net profit rose 3.9% to €303.8 million, and adjusted EPS reached €0.68, up 9.8% at constant currency. Organic growth accelerated from 4.5% in Q1 to 5.5% in Q2, led by Marine and data-center-related Buildings & Infrastructure activity. Management upgraded FY 2026 organic growth guidance to mid-to-high single digits and maintained expectations for margin improvement and cash conversion above 90%. Valuation is reasonable at 17.8x 2026e P/E, 11.7x EV/EBITDA, and 15.3x price/free cash flow versus peer medians of 19.5x, 12.5x, and 17.0x. Near-term catalysts include further organic acceleration, LEAP | 28 disposals, LotusWorks integration, buybacks, and the data-center and energy-transition pipeline.